LAWSON, JOHN DAVID,SABAT, MARK,SCORAH, NICHOLAS,SMITH, CHRISTOPHER,VU, PHONG H.,WANG, HAIXIA
申请号：
SG11201506112Q
公开号：
SG11201506112QA
申请日:
2014.03.10
申请国别(地区):
SG
年份:
2015
代理人:
摘要：
Disclosed are compounds of Formula 1, or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , and R 4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating Type I hypersensitivity reactions, autoimmune diseases, inflammatory disorders, cancer, non-malignant proliferative disorders, and other conditions associated with BTK.
